Report cover image

Global CRISPR Market - 2025-2033

Published Mar 27, 2026
Length 223 Pages
SKU # DTAM21122966

Description

Global CRISPR Market Overview:
The Global CRISPR Market was valued at US$ 4.59 billion in 2025 and is anticipated to reach US$ 15.25 billion by 2033, at a CAGR of 0.168 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Global CRISPR Market.

This report delivers a comprehensive overview of the Global CRISPR Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Global CRISPR Market. The Global CRISPR Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2025–2033.

Global CRISPR Market Scope:
Key Players
• Thermo Fisher Scientific, Inc.

Major Highlights
This report delivers a comprehensive overview of the Global CRISPR Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Global CRISPR Market. The Global CRISPR Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2025–2033.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
South America (Colombia, Brazil, Argentina, Rest of South America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification
Increase Your Customer Base by 3X using our Partner Identification tool
Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?
• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

223 Pages
1. Market Introduction and Scope
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. Executive Insights and Key Takeaways
3. Market Highlights and Strategic Takeaways
3.1. Key Trends and Future Projections
3.1.1. Snippet by Product Type
3.1.2. Snippet by Application
3.1.3. Snippet by End-User
3.1.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rapid Advancements in Gene Editing Technologies.
4.1.1.2. Increasing Demand for Personalized and Targeted Therapies
4.1.1.3. XX
4.1.2. Restraints
4.1.2.1. High costs Associated with Advanced CRISPR Tools and Technologies
4.1.2.2. Risk of off-target Effects and Unintended Genetic Changes
4.1.2.3. XX
4.1.3. Opportunity
4.1.3.1. Expanding Use of CRISPR in Drug Discovery, Diagnostics, and Agriculture
4.1.3.2. XX
4.1.4. Impact Analysis
5. Strategic Insights and Industry Outlook
5.1. Market Leaders and Pioneers
5.1.1. Emerging Pioneers and Prominent Players
5.1.2. Established leaders with largest selling Brand
5.1.3. Market leaders with established Product
5.2. Latest Developments and Breakthroughs
5.3. Regulatory and Reimbursement Landscape
5.3.1. North America
5.3.2. Europe
5.3.3. Asia Pacific
5.3.4. South America
5.3.5. Middle East & Africa
5.4. Porter’s Five Forces Analysis
5.5. Supply Chain Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. Unmet Needs and Gaps
5.9. Recommended Strategies for Market Entry and Expansion
5.10. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
5.11. Pricing Analysis and Price Dynamics
6. CRISPR Market, By Product Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
6.1.2. Market Attractiveness Index, By Product Type
6.2. CRISPR kits & Consumables*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. CRISPR Libraries
6.4. Others
7. CRISPR Market, By Application
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Drug Discovery & Development*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Agriculture
7.4. Others
8. CRISPR Market, By End-User
9. Introduction
9.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.1. Market Attractiveness Index, By End-User
9.2. Pharmaceutical Companies*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Biotechnology Companies
9.4. Academic & Research Institutes
9.5. Others
10. CRISPR Market, By Regional Market Analysis and Growth Opportunities
11. Introduction
11.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.1. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.1. U.S.
12.1.1. Canada
12.1.1.1. Mexico
12.2. Europe
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.6.1. Germany
12.2.6.2. U.K.
12.2.6.3. France
12.2.6.4. Spain
12.2.6.5. Italy
12.2.6.6. Rest of Europe
12.3. South America
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.6.1. Brazil
12.3.6.2. Argentina
12.3.6.3. Rest of South America
12.4. Asia-Pacific
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.6.1. China
12.4.6.2. India
12.4.6.3. Japan
12.4.6.4. South Korea
12.4.6.5. Rest of Asia-Pacific
12.5. Middle East and Africa
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
13. Competitive Landscape and Market Positioning
14. Competitive Overview and Key Market Players
14.1. Market Share Analysis and Positioning Matrix
14.2. Strategic Partnerships, Mergers & Acquisitions
14.3. Key Developments in Product Portfolios and Innovations
14.4. Company Benchmarking
15. Company Profiles
15.1. Thermo Fisher Scientific, Inc.*
15.1.1. Company Overview
15.1.2. Product Portfolio
15.1.2.1. Product Description
15.1.2.2. Product Key Performance Indicators (KPIs)
15.1.2.3. Historic and Forecasted Product Sales
15.1.2.4. Product Sales Volume
15.1.3. Financial Overview
15.1.3.1. Company Revenue
15.1.3.1.1. Geographical Revenue Shares
15.1.3.1.1.1. Revenue Forecasts
15.1.3.1.2. Key Developments
15.1.3.1.2.1. Mergers & Acquisitions
15.1.3.1.2.2. Key Product Development Activities
15.1.3.1.2.3. Regulatory Approvals, etc.
15.1.3.1.3. SWOT Analysis
15.1.4. Merck KGaA
15.1.5. Agilent Technologies, Inc.
15.1.6. GenScript
15.1.7. Creative Biogene
15.1.8. Bio-Rad Laboratories, Inc.
15.1.9. Takara Bio Inc.
15.1.10. QIAGEN
15.1.11. Eurofins Genomics
15.1.12. Synthego(LIST NOT EXHAUSTIVE)
16. Assumption and Research Methodology
16.1. Data Collection Methods
16.2. Data Triangulation
16.3. Forecasting Techniques
16.4. Data Verification and Validation
17. Appendix
17.1. About Us and Services
17.2. Contact Us
Suggestions for Related Report
• Prime Editing and CRISPR Market (https://www.datamintelligence.com/research-report/prime-editing-and-crispr-market)
• CRISPR-Based Diagnostics Market (https://www.datamintelligence.com/research-report/crispr-based-diagnostics-market)
• Gene Editing Tools Market (https://www.datamintelligence.com/research-report/gene-editing-tools-market)
For more biotechnology-related reports, please click here (https://www.datamintelligence.com/industry-verticals/biotechnology)
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.